Tリンパ球性白血病、T細胞白血病
- 関
- T-cell leukemia、T-cell lymphocytic leukemia
WordNet
- malignant neoplasm of blood-forming tissues; characterized by abnormal proliferation of leukocytes; one of the four major types of cancer (同)leukaemia, leucaemia, cancer of the blood
- the 20th letter of the Roman alphabet (同)t
- of or relating to lymphocytes; "lymphocytic leukemia"
- a tough youth of 1950s and 1960s wearing Edwardian style clothes (同)Teddy boy
PrepTutorEJDIC
- 白血病
- tritiumの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.
- Johansson P1,2, Bergmann A3, Rahmann S4, Wohlers I4, Scholtysik R2, Przekopowitz M2, Seifert M2, Tschurtschenthaler G5, Webersinke G5, Jäger U6, Siebert R3, Klein-Hitpass L2, Dührsen U1, Dürig J1, Küppers R2.
- International journal of cancer. Journal international du cancer.Int J Cancer.2016 Jan 1;138(1):121-4. doi: 10.1002/ijc.29697. Epub 2015 Jul 30.
- The pathogenesis of T-cell large granular lymphocytic leukemia (T-LGL) is poorly understood, as STAT3 mutations are the only known frequent genetic lesions. Here, we identified non-synonymous alterations in the TNFAIP3 tumor suppressor gene in 3 of 39 T-LGL. In two cases these were somatic mutations
- PMID 26199174
- Idelalisib-associated Enterocolitis: Clinicopathologic Features and Distinction From Other Enterocolitides.
- Louie CY1, DiMaio MA, Matsukuma KE, Coutre SE, Berry GJ, Longacre TA.
- The American journal of surgical pathology.Am J Surg Pathol.2015 Dec;39(12):1653-60. doi: 10.1097/PAS.0000000000000525.
- Idelalisib is a highly specific small-molecule phosphoinositide-3-kinase δ inhibitor that was recently approved by the Food and Drug Administration for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma. The known side effects of idelalisib include seve
- PMID 26426383
- Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.
- Aggarwal N1, Pongpruttipan T, Patel S, Bayerl MG, Alkan S, Nathwani B, Surti U, Kitahara S, Chinthammitr Y, Swerdlow SH.
- The American journal of surgical pathology.Am J Surg Pathol.2015 Dec;39(12):1679-87. doi: 10.1097/PAS.0000000000000496.
- S100 T-cell lymphomas are infrequent, and except 1 all have been CD4 negative. On the basis of an index case of CD4 S100 T-cell prolymphocytic leukemia (T-PLL), we studied S100 protein expression in 19 additional T-PLLs and 56 other T-cell lymphomas that are usually CD4, including 15 angioimmunoblas
- PMID 26379148
Japanese Journal
- Tea Catechins Inhibit Cell Proliferation Through Hydrogen Peroxide-Dependent and -Independent Pathways in Human T lymphocytic Leukemia Jurkat Cells
- , , , , ,
- Food Science and Technology Research 20(6), 1245-1249, 2014
- … In the present study, we investigated the anti-proliferative effects of four tea catechins: (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECg) and (-)-epigallocatechin gallate (EGCg) in human T lymphocytic leukemia Jurkat cells. …
- NAID 130004848141
- Lymphoma in Asia : smoldering ATL の治療戦略
- 塚崎 邦弘
- Skin cancer : official organ of the Japanese Society for Skin Cancer = 皮膚悪性腫瘍研究会機関誌 24(2), 199-205, 2009-10-10
- … ヒトTリンパ球好性ウイルスI型(HTLV-1)が病因である成人T細胞白血病・リンパ腫(ATL)は,無治療でも数年以上病勢が進行しないことがあるindolent ATL(慢性型/くすぶり型)から数週間で死に至ることが多いaggressive ATL(急性型/リンパ腫型)まで,臨床病態は多様である。 …
- NAID 10030441178
- Effects of Dexamethasone and Aminophylline on Survival of Jurkat and HL-60 Cells(Pharmacology)
- , , [他], ,
- Biological & pharmaceutical bulletin 29(2), 281-285, 2006-02-01
- … The effects of dexamethasone and aminophylline on survival of Jurkat T-lymphocytic leukemia cells and HL-60 promyelocytic leukemia cells were investigated. …
- NAID 110005663959
Related Links
- Learn about statistics, symptoms and signs, diagnosis, stages, treatment options, clinical trials, research, and more in this Cancer.Net Guide to Chronic T-Cell Lymphocytic Leukemia. ... ON THIS PAGE: You will find some basic ...
- INTRODUCTION T-cell large granular lymphocytic (T-LGL) leukemia is characterized by a monoclonal expansion of CD3-positive T-LGL cells, as described in 1975 (1). This rare and indolent disorder represents 2% to 3% of chronic ...
★リンクテーブル★
[★]
- 英
- T-cell leukemia、T-lymphocytic leukemia、T-cell lymphocytic leukemia
- 関
- Tリンパ球性白血病
[★]
Tリンパ球性白血病、T細胞白血病
- 関
- T-cell leukemia、T-lymphocytic leukemia
[★]
- 英
- T-lymphocytic leukemia、T-cell lymphocytic leukemia
- 関
- T細胞白血病
[★]
T細胞白血病
- 関
- T-cell lymphocytic leukemia、T-lymphocytic leukemia
[★]
[★]
- 関
- lymphatic